Clinical Trials Browser

Recruiting × INDUSTRY × relatlimab × Clear all

Neoplasms

NCT06743126 2026-05-29

SUPRAME

Phase 3 Recruiting

360 enrolled

Dermatologic

Melanoma, Cutaneous Malignant

NCT05176483 2026-05-27

STELLAR-002

Phase 1 Recruiting

1,314 enrolled

GastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT06561386 2026-05-20

RELATIVITY1093

Phase 3 Recruiting

1,000 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06624644 2026-04-22

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Phase 2/3 Recruiting

135 enrolled

Dermatologic

Melanoma

Clinical Trials

Pan Tumor Rollover Study

SUPRAME

STELLAR-002

RELATIVITY1093

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma